CTLA4-IgG ameliorates homocysteine-accelerated atherosclerosis by inhibiting T-cell overactivation in apoE-/- mice

Cardiovascular Research

Volumn 97, Issue 2, 2013, Pages 349-359

  Ma, Kongyang ^a,b   Lv, Silin ^a,b   Liu, Bo ^a,b   Liu, Ziyi ^a,b   Luo, Yuhong ^a,b   Kong, Wei ^a,b   Xu, Qingbo ^c   Feng, Juan ^a,b   Wang, Xian ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Atherosclerosis; CTLA4 IgG; Homocysteine; Overactivation; T cell

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ABATACEPT; APOLIPOPROTEIN E; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; HOMOCYSTEINE; IMMUNOGLOBULIN G;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL VACUOLE; CHOLESTEROL BLOOD LEVEL; COMPETITIVE INHIBITION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; DOWN REGULATION; ENDOCYTOSIS; ENDOSOME; FEMALE; FLOW CYTOMETRY; HYPERHOMOCYSTEINEMIA; IMMUNOHISTOCHEMISTRY; LYSOSOME; MACROPHAGE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD28; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CTLA-4 ANTIGEN; ENDOCYTOSIS; FEMALE; HYPERHOMOCYSTEINEMIA; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES;

EID: 84872590494     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs330     Document Type: Article

References (45)

1. Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol 2009;27:165-197.
2. Weyand CM, Younge BR, Goronzy JJ. T cells in arteritis and atherosclerosis. Curr Opin Lipidol 2008;19:469-477.
3. Millonig G, Malcom GT, Wick G. Early inflammatory-immunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY)-study. Atherosclerosis 2002;160:441-448.
4. Feng J, Zhang Z, Kong W, Liu B, Xu Q, Wang X. Regulatory T cells ameliorate hyperhomocysteinaemia-accelerated atherosclerosis in apo E2/2 mice. Cardiovasc Res 2009;84:155-163.
5. Zhang Q, Zeng X, Guo J, Wang X. Oxidant stress mechanism of homocysteine potentiating Con A-induced proliferation in murine splenic T lymphocytes. Cardiovasc Res 2002;53:1035-1042.
6. Sehajpal PK, Sharma VK, Stenzel KH, Suthanthiran M. Two-signal model for T-cell activation: molecular mechanisms. Transplant Proc 1993;25:104-105.
7. Bernard A, Lamy AL, Alberti I. The two-signal model of T-cell activation after 30 years. Transplantation 2002;73:S31-35.
8. Teft WA, Kirchhof MG, Madrenas J. A molecular perspective of CTLA-4 function. Annu Rev Immunol 2006;24:65-97.
9. Qureshi OS, Zheng Y, Nakamura K, Attridge K, Manzotti C, Schmidt EM et al. Transendocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 2011;332:600-603.
10. Iida T, Ohno H, Nakaseko C, Sakuma M, Takeda-Ezaki M, Arase H et al. Regulation of cell surface expression of CTLA-4 by secretion of CTLA-4-containing lysosomes upon activation of CD4+ T cells. J Immunol 2000;165:5062-5068.
11. Chuang E, Alegre ML, Duckett CS, Noel PJ, Vander Heiden MG, Thompson CB. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. J Immunol 1997; 159:144-151.
12. Alten R, Marker-Hermann E. [Selective co-stimulation blockade. CTLA4-Ig (Abatacept)]. Z Rheumatol 2010;69:601-607.
13. Lin H, Rathmell JC, Gray GS, Thompson CB, Leiden JM, Alegre ML. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. J Exp Med 1998;188:199-204.
14. Padrid PA, Mathur M, Li X, Herrmann K, Qin Y, Cattamanchi A et al. CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma. Am J Resp Cell Mol Biol 1998;18:453-462.
15. Wang X, Huang W, Mihara M, Sinha J, Davidson A. Mechanism of action of combined short-term CTLA4Ig and anti-CD40 ligand in murine systemic lupus erythematosus. J Immunol 2002;168:2046-2053.
16. Mead KI, Zheng Y, Manzotti CN, Perry LC, Liu MK, Burke F et al. Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1 and stimulated during activation of regulatory T cells. J Immunol 2005;174:4803-4811.
17. Fu Y, Hou Y, Fu C, Gu M, Li C, Kong W et al. A novel mechanism of gamma/delta T-lymphocyte and endothelial activation by shear stress: the role of ecto-ATP synthase beta chain. Circ Res 2011;108:410-417.
18. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009;15:914-920.
19. Jiang Y, Zhao J, Jiang T, Ge L, Zhou F, Chen Z et al. Genetic polymorphism of methylenetetrahydrofolate reductase G1793A, hyperhomocysteinemia, and folate deficiency correlate with ulcerative colitis in central China. J Gastroenterol Hepatol 2010;25:1157-1161.
20. Khallou-Laschet J, Caligiuri G, Groyer E, Tupin E, Gaston AT, Poirier B et al. The proatherogenic role of T cells requires cell division and is dependent on the stage of the disease. Arterioscler Thromb Vasc Biol 2006;26:353-358.
21. Webb LM, Walmsley MJ, Feldmann M. Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2. Eur J Immunol 1996;26:2320-2328.
22. Martin M, Schneider H, Azouz A, Rudd CE. Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function. J Exp Med 2001;194:1675-1681.
23. Gharbi SI, Zvelebil MJ, Shuttleworth SJ, Hancox T, Saghir N, Timms JF et al. Exploring the specificity of the PI3K family inhibitor LY294002. Biochem J 2007;404:15-21.
24. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003;423:506-511.
25. Downey J, Smith A, Schneider H, Hogg N, Rudd CE. TCR/CD3 mediated stop-signal is decoupled in T-cells from Ctla4 deficient mice. Immunol Lett 2008;115:70-72.
26. Alegre ML, Noel PJ, Eisfelder BJ, Chuang E, Clark MR, Reiner SL et al. Regulation of surface and intracellular expression of CTLA4 on mouse T cells. J Immunol 1996;157: 4762-4770.
27. Wilson JM, de Hoop M, Zorzi N, Toh BH, Dotti CG, Parton RG. EEA1, a tethering protein of the early sorting endosome, shows a polarized distribution in hippocampal neurons, epithelial cells, and fibroblasts. Mol Biol Cell 2000;11:2657-2671.
28. Eskelinen EL. Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol Aspects Med 2006;27:495-502.
29. Kane LP, Andres PG, Howland KC, Abbas AK, Weiss A. Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not TH2 cytokines. Nat Immunol 2001;2:37-44.
30. Thompson CB, Lindsten T, Ledbetter JA, Kunkel SL, Young HA, Emerson SG et al. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc Natl Acad Sci USA 1989;86:1333-1337.
31. Buono C, Pang H, Uchida Y, Libby P, Sharpe AH, Lichtman AH. B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in lowdensity lipoprotein receptor-deficient mice. Circulation 2004;109:2009-2015.
32. Afek A, Harats D, Roth A, Keren G, George J. Evidence for the involvement of T cell costimulation through the B-7/CD28 pathway in atherosclerotic plaques from apolipoprotein E knockout mice. Exp Mol Pathol 2004;76:219-223.
33. Krummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med 1995;182:459-465.
34. Jones RG, Elford AR, Parsons MJ, Wu L, Krawczyk CM, Yeh WC et al. CD28-dependent activation of protein kinase B/Akt blocks Fas-mediated apoptosis by preventing death-inducing signaling complex assembly. J Exp Med 2002;196: 335-348.
35. Boussiotis VA, Freeman GJ, Gribben JG, Nadler LM. The critical role of CD28 signalling in the prevention of human T-cell anergy. Res Immunol 1995;146:140-149.
36. Wells AD, Walsh MC, Bluestone JA, Turka LA. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. J Clin Invest 2001;108:895-903.
37. Shahinian A, Pfeffer K, Lee KP, Kundig TM, Kishihara K, Wakeham A et al. Differential T cell costimulatory requirements in CD28-deficient mice. Science 1993;261: 609-612.
38. Walker LS, Sansom DM. The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses. Nat Rev Immunol 2011;11:852-863.
39. Barrat FJ, Le Deist F, Benkerrou M, Bousso P, Feldmann J, Fischer A et al. Defective CTLA-4 cycling pathway in Chediak-Higashi syndrome: a possible mechanism for deregulation of T lymphocyte activation. Proc Natl Acad Sci USA 1999;96:8645-8650.
40. Schwartz JC, Zhang X, Nathenson SG, Almo SC. Structural mechanisms of costimulation. Nat Immunol 2002;3:427-434.
41. SchneiderH,MartinM,Agarraberes FA, Yin L, Rapoport I, Kirchhausen Tet al.Cytolytic T lymphocyte-associated antigen-4 and the TCR zeta/CD3 complex, but not CD28, interact with clathrin adaptor complexes AP-1 and AP-2. J Immunol 1999;163:1868-1879.
42. Anogeianaki A, Angelucci D, Cianchetti E, D'Alessandro M, Maccauro G, Saggini A et al. Atherosclerosis: a classic inflammatory disease. Int J Immunopathol Pharmacol 2012;24:817-825.
43. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-126.
44. Greaves DR, Channon KM. Inflammation and immune responses in atherosclerosis. Trends Immunol 2002;23:535-541.
45. Dejaco C, Duftner C, Wipfler E, Schirmer M. A novel treatment option in rheumatoid arthritis: abatacept, a selective modulator of T-cell co-stimulation. Wien Med Wochenschr 2009;159:70-75.